Explore 3 Stock Ideas & Industry Insights Download Free Report

Hydreight Technologies Inc

Company price
3.09 CAD 0.07 ( 2.32%)
Last update at 2026-11-04T14:39:00Z
VOLUME
5100
Market Cap
192.13M
P/E
406.00

Momentum Score

…

Hydreight Technologies Inc. provides operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides with respect to various services, such as wide ranging IV therapy treatments, GLP1, NAD, Botox, and fillers; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. In addition, the company offers an online pharmacy, which allow its network of medical practitioners to purchase pharmacy products from federally regulated pharmacies. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
3.07
Low
3.09
High
52 Week Price Range
1.46
Low
5.59
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Hydreight Technologies Inc (NURS.V) is limited, with filings and disclosures providing little detail about its core operations. If pursuing technology or health‑related commercialization, long‑term growth drivers could include product development, regulatory approvals and market expansion, and investors may find potential upside if management executes these stages.
Key risks include early‑stage execution and financing uncertainty, thin trading liquidity and regulatory or market access obstacles that could materially impair prospects.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
3.02
Dividend Yield
-
Revenue TTM
24.48M
Revenue Per Share
0.56
Gross Profit TTM
7.14M
Debt / Equity
-
ROE
11.78%
Net Debt
-
ROCE
-31.33%
Diluted EPS TTM
0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.41M -1.94M -6.00M -0.52M -0.23M
Net income -0.41M -1.94M -6.00M -0.53M -0.23M
Selling general administrative 5.46M 5.73M 3.11M 0.99M 0.42M
Gross profit 5.70M 4.96M 1.84M 0.64M 0.32M
Reconciled depreciation 0.18M 0.11M 0.04M 0.00M -
Operating income 0.29M -1.47M -1.96M -0.44M -0.23M
Interest expense - 0.00M 0.00M 0.00M -
Tax provision - - 0.00M 0.01M 0.00M
Interest income 0.02M 0.02M 0.00M - -
Net interest income -0.72M -0.45M -0.10M -0.08M -
Total revenue 16.04M 11.51M 4.27M 1.20M 0.45M
Total operating expenses 15.75M 12.97M 6.23M 1.64M 0.68M
Cost of revenue 10.35M 6.55M 2.43M 0.56M 0.13M
Total other income expense net 0.02M -0.02M -3.93M -0.00M -
Net income from continuing ops -0.41M -1.94M -6.00M -0.53M -0.23M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 3.11M 2.60M 2.89M 0.43M 0.04M
Intangible assets 1.53M - - - -
Total liab 4.88M 4.43M 3.25M 1.21M 0.29M
Total stockholder equity -1.77M -1.83M -0.36M -0.78M -0.25M
Capital stock 7.10M 6.53M 6.23M 0.00M 0.00M
Retained earnings -9.13M -8.73M -6.79M -0.79M -0.27M
Cash 1.19M 1.78M 2.43M 0.01M 0.03M
Total current liabilities 4.04M 4.41M 3.23M 1.20M 0.29M
Total current assets 1.58M 2.06M 2.62M 0.05M 0.04M
Net receivables 0.08M 0.02M 0.01M - -
Inventory 0.00M 0.10M 0.10M 0.00M -
Accounts payable 1.01M 1.90M 0.75M 0.40M 0.02M
Non current assets total 1.53M 0.54M 0.27M 0.38M 0.00M
Capital lease obligations - 0.00M 0.02M 0.00M -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -1.18M -0.30M -0.07M -0.38M 0.00M
Total cash from financing activities -0.06M 0.03M 2.82M 0.50M -0.00M
Net income -0.41M -1.94M -6.00M -0.53M -0.23M
Change in cash -0.60M -0.65M 2.43M -0.03M 0.03M
Begin period cash flow 1.78M 2.43M 0.01M 0.03M 0.00M
End period cash flow 1.19M 1.78M 2.43M 0.01M 0.03M
Total cash from operating activities 0.86M -0.40M -0.33M -0.15M 0.02M
Issuance of capital stock - 0.00M 0.35M 0.00M -
Depreciation 0.18M 0.11M 0.04M 0.00M -
Change to inventory 0.00M 0.00M -0.26M 0.00M -
Change to account receivables -0.05M -0.02M -0.01M - -
Sale purchase of stock -0.01M 0.00M - - -
Capital expenditures 1.18M 0.21M 0.07M 0.38M 0.00M
Change in working capital 0.37M 0.98M 1.30M 0.38M 0.25M
Stock based compensation 0.61M 0.44M 0.30M 0.00M -
Other non cash items - 0.00M 3.86M - -
Free cash flow -0.33M -0.61M -0.40M -0.53M 0.02M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NURS
Hydreight Technologies Inc
0.07
2.32%
3.09 406.00 25.91 7.85 20.38 7.45 109.02
ADK
Diagnos Inc
-
-%
0.35 - 10.00 411.24 18.74 389.06 -6.16
NXG
NexgenRX Inc.
-
-%
0.66 39.00 32.68 1.55 4.64 1.39 7.84
PTEC
Principal Technologies Inc
-
-%
0.32 - - 62.75 355.42 72.08 -0.81
CHS
Comprehensive Healthcare Systems Inc
-
-%
0.33 - - 4.44 13.23 3.83 26.88

Profile*

Hydreight Technologies Inc

Hydreight Technologies Inc. provides operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides with respect to various services, such as wide ranging IV therapy treatments, GLP1, NAD, Botox, and fillers; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. In addition, the company offers an online pharmacy, which allow its network of medical practitioners to purchase pharmacy products from federally regulated pharmacies. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada.

7251 West Lake Mead Boulevard, Las Vegas, NV, United States, 89128

Name Title Year Born
Shane Madden CEO & Director NA
Mr. Joshua Sorin CFO & Corp. Sec. NA
Mr. Shane Madden CEO & Director NA
Mr. Joshua Sorin CFO & Corporate Secretary NA
Mr. Vahid Shababi Shad Chief Operating Officer NA
Ms. Abbey Vogt Operations Manager NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…